AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20118830 — intervention group
Group type: COMPARATOR
Intervention: 2-session skills-building only comparison intervention (n = 31)
Number of subjects: 79
Study 17628185 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (various forms)
Number of subjects: 0
Study 17628185 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E analogues
Number of subjects: 0
Study 17628185 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E-based compounds
Number of subjects: 0
Study 15530579 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient self-report
Number of subjects: 173
Study 15530579 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctor assessment
Number of subjects: 173
Study 15530579 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse assessment
Number of subjects: 173
Study 15530579 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine isoniazid levels
Number of subjects: 173
Study 15530579 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized pill bottles
Number of subjects: 173
Study 12200244 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiologist-controlled radiation exposure
Number of subjects: 368
Study 12200244 — intervention group
Group type: COMPARATOR
Intervention: Radiographer-controlled radiation exposure
Number of subjects: 368
Study 12200244 — intervention group
Group type: EXPERIMENTAL
Intervention: Consultant cardiologists
Number of subjects: 368
Study 12200244 — intervention group
Group type: COMPARATOR
Intervention: Registrars
Number of subjects: 368
Study 9865556 — intervention group
Group type: EXPERIMENTAL
Intervention: Teflon stent
Number of subjects: 42
Study 9865556 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene stent
Number of subjects: 42
Study 8536155 — intervention group
Group type: EXPERIMENTAL
Intervention: RISCC scoring system
Number of subjects: 622
Study 8536155 — intervention group
Group type: EXPERIMENTAL
Intervention: FRR scoring system
Number of subjects: 622
Study 2195580 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (150 mg in decaffeinated coffee)
Number of subjects: 20
Study 2195580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 402926 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorimetric assay of minocycline in plasma
Number of subjects: 0
Study 402926 — intervention group
Group type: COMPARATOR
Intervention: Conventional large plate agar diffusion microbiological assay
Number of subjects: 0
Study 30385098 — intervention group
Group type: EXPERIMENTAL
Intervention: Education Booklet
Number of subjects: 60
Study 30385098 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal Education
Number of subjects: 60
Study 30385098 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 30385098 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between Booklet and Verbal Education
Number of subjects: 60
Study 28657933 — intervention group
Group type: EXPERIMENTAL
Intervention: Myeloablative conditioning (MAC)
Number of subjects: 113
Study 28657933 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-intensity conditioning (RIC)
Number of subjects: 113
Study 28657933 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmyeloablative conditioning (NMC)
Number of subjects: 113
Study 28657933 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoid low dose (≤9 mg·kg prednisone)
Number of subjects: 113
Study 28657933 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoid high dose (>9 mg·kg prednisone)
Number of subjects: 113
Study 25998068 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular pacing
Number of subjects: 43
Study 25998068 — intervention group
Group type: COMPARATOR
Intervention: Atrial pacing
Number of subjects: 43
Study 25998068 — intervention group
Group type: COMPARATOR
Intervention: No pacing
Number of subjects: 43
Study 24461664 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (30 mg/kg once a week for up to 24 months)
Number of subjects: 89
Study 24461664 — intervention group
Group type: COMPARATOR
Intervention: Placebo (once a week for up to 24 months)
Number of subjects: 89
Study 24461664 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 89
Study 24461664 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 21723353 — intervention group
Group type: EXPERIMENTAL
Intervention: IXIARO(®) high titer sera (PRNT(50) titer ∼200)
Number of subjects: 10
Study 21723353 — intervention group
Group type: EXPERIMENTAL
Intervention: JE‐VAX(®) high titer sera (PRNT(50) titer ∼55)
Number of subjects: 10
Study 21723353 — intervention group
Group type: COMPARATOR
Intervention: Non-immune serum groups
Number of subjects: 10
Study 21723353 — intervention group
Group type: EXPERIMENTAL
Intervention: IXIARO(®) sera with titer ≥10
Number of subjects: 10
Study 21723353 — intervention group
Group type: EXPERIMENTAL
Intervention: Different doses of IXIARO
Number of subjects: 10
Study 19317104 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium (Spiriva)
Number of subjects: 5993
Study 16434206 — intervention group
Group type: EXPERIMENTAL
Intervention: Active warming with a forced-air warming device
Number of subjects: 40
Study 16434206 — intervention group
Group type: COMPARATOR
Intervention: Warm mattresses and cotton blankets (Control)
Number of subjects: 40
Study 15631874 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (17.5 mg)
Number of subjects: 12
Study 15631874 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day, 5 days weekly for 6 months, 3 days weekly at month 7 and 1 day/week at month 8)
Number of subjects: 12
Study 15631874 — intervention group
Group type: EXPERIMENTAL
Intervention: Both nicotine and fluoxetine
Number of subjects: 12
Study 11334145 — intervention group
Group type: EXPERIMENTAL
Intervention: LR‐3280 (doses from 1 to 24 mg) administered into target vessel through a guiding catheter
Number of subjects: 78
Study 11334145 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 78
Study 9327151 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin 10 mg/m2 every 2 weeks with bleomycin 10 U/m2 and vincristine 1.4 mg/m2, zidovudine 100 mg five times daily, and rhGM-CSF 5 micrograms/kg/day
Number of subjects: 20
Study 9327151 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM-CSF at doses of 2.5 to 5 micrograms/kg
Number of subjects: 20
Study 9327151 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin 20 mg/m2
Number of subjects: 20
Study 9113010 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy (EST)
Number of subjects: 202
Study 9113010 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic balloon dilation (EBD)
Number of subjects: 202
Study 2576359 — intervention group
Group type: EXPERIMENTAL
Intervention: Picumast dihydrochloride (10 mg)
Number of subjects: 12
Study 2576359 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (7 mg/kg b.w.)
Number of subjects: 12
Study 2576359 — intervention group
Group type: EXPERIMENTAL
Intervention: Picumast dihydrochloride (10 mg) and Theophylline (7 mg/kg b.w.) combined
Number of subjects: 12
Study 1105483 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin 5 mg three or four times a day
Number of subjects: 20
Study 1105483 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin in combination with polythiazide
Number of subjects: 20
Study 1105483 — intervention group
Group type: COMPARATOR
Intervention: Prazosin alone
Number of subjects: 20
Study 1105483 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 20
Study 30896368 — intervention group
Group type: EXPERIMENTAL
Intervention: Region closest to the railyard
Number of subjects: 965
Study 30896368 — intervention group
Group type: COMPARATOR
Intervention: Region furthest from the railyard
Number of subjects: 965
Study 27779571 — intervention group
Group type: EXPERIMENTAL
Intervention: Desvenlafaxine
Number of subjects: 119
Study 25692717 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhetorical question (RQ) intervention
Number of subjects: 445
Study 25692717 — intervention group
Group type: COMPARATOR
Intervention: One-sided message
Number of subjects: 445
Study 25692717 — intervention group
Group type: COMPARATOR
Intervention: Two-sided message
Number of subjects: 445
Study 25692717 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall intervention
Number of subjects: 445
Study 23507121 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest tube removal on full inspiration
Number of subjects: 342
Study 23507121 — intervention group
Group type: COMPARATOR
Intervention: Chest tube removal on full expiration
Number of subjects: 342
Study 21795888 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) during wound debridement for 6 minutes
Number of subjects: 12
Study 21795888 — intervention group
Group type: COMPARATOR
Intervention: Standard of care pharmacologies during wound debridement for 6 minutes
Number of subjects: 12
Study 19424085 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine (8 mg/day for 4 weeks then 16 mg/day for another 4 weeks)
Number of subjects: 20
Study 19424085 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 16450235 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive web-based curriculum on EBM
Number of subjects: 238
Study 16450235 — intervention group
Group type: COMPARATOR
Intervention: Traditional clerkship experience
Number of subjects: 238
Study 15069728 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy (ES) before plastic stent (PS) placement
Number of subjects: 172
Study 15069728 — intervention group
Group type: COMPARATOR
Intervention: Plastic stent (PS) placement without endoscopic sphincterotomy (ES)
Number of subjects: 172
Study 11760917 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediation group
Number of subjects: 48
Study 11760917 — intervention group
Group type: COMPARATOR
Intervention: Standard procedure group
Number of subjects: 48
Study 9230143 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release niacin
Number of subjects: 29
Study 9230143 — intervention group
Group type: COMPARATOR
Intervention: Regular niacin
Number of subjects: 29
Study 8477561 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (50 mg/day for 5 days)
Number of subjects: 44
Study 8477561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 2457403 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide 1 mg
Number of subjects: 28
Study 2457403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 31280757 — intervention group
Group type: EXPERIMENTAL
Intervention: MDD group
Number of subjects: 343
Study 31280757 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 343
Study 31434935 — intervention group
Group type: EXPERIMENTAL
Intervention: B. coagulans Unique IS2 (2 billion CFU)
Number of subjects: 136
Study 31434935 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 136
Study 28468642 — intervention group
Group type: EXPERIMENTAL
Intervention: Short cognitive behavioural therapy (CBT)-based treatment by mental health nurse practitioners (MHNPs) in addition to usual GP care
Number of subjects: 212
Study 28468642 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 212
Study 28468642 — intervention group
Group type: EXPERIMENTAL
Intervention: Short cognitive behavioural therapy (CBT)-based treatment by MHNPs
Number of subjects: 212
Study 25469669 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching primer (SEP)
Number of subjects: 89
Study 25469669 — intervention group
Group type: COMPARATOR
Intervention: 37% phosphoric acid etch (ETCH)
Number of subjects: 89
Study 23426618 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone infusion
Number of subjects: 15
Study 23426618 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (Control)
Number of subjects: 15
Study 21978713 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral desensitisation with cow's milk
Number of subjects: 4
Study 21978713 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral desensitisation with hen's egg
Number of subjects: 4
Study 21978713 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral desensitisation with cow's milk and hen's egg
Number of subjects: 4
Study 21978713 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral desensitisation with raw hen's egg
Number of subjects: 4
Study 18194401 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (HDC)
Number of subjects: 314
Study 18194401 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 314
Study 16612399 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic administration of antioxidant compounds, such as acetylcysteine and ascorbic acid
Number of subjects: 0
Study 16612399 — intervention group
Group type: COMPARATOR
Intervention: Vasodilators and diuretics
Number of subjects: 0
Study 12699035 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 192
Study 12699035 — intervention group
Group type: COMPARATOR
Intervention: Control group from RCTs
Number of subjects: 192
Study 10900811 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management training
Number of subjects: 30
Study 10900811 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 30
Study 8612383 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal mode inhalation technique
Number of subjects: 14
Study 8612383 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary mode inhalation technique
Number of subjects: 14
Study 1343207 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured evaluation form
Number of subjects: 203
Study 1343207 — intervention group
Group type: COMPARATOR
Intervention: Open-ended evaluation form
Number of subjects: 203
Study 1343207 — intervention group
Group type: COMPARATOR
Intervention: Instructional videotape
Number of subjects: 203
Study 1343207 — intervention group
Group type: EXPERIMENTAL
Intervention: General internists
Number of subjects: 203
Study 1343207 — intervention group
Group type: EXPERIMENTAL
Intervention: University hospital faculty
Number of subjects: 203
Study 6141436 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy every 8 weeks for 2 years
Number of subjects: 162
Study 6141436 — intervention group
Group type: COMPARATOR
Intervention: Observation only
Number of subjects: 162
Study 6141436 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients above 40 years
Number of subjects: 162
Study 6141436 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients aged 40 and below
Number of subjects: 162
Study 31530065 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Number of subjects: 70
Study 31530065 — intervention group
Group type: COMPARATOR
Intervention: In-person care
Number of subjects: 70
Study 30238584 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus ointment plus 308 nm excimer lamp
Number of subjects: 21
Study 30238584 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment plus 308 nm excimer lamp plus fractional CO2 laser
Number of subjects: 21
Study 30118569 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen membrane (CM) with bone substitute
Number of subjects: 52
Study 30118569 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated growth factor (CGF) with bone substitute
Number of subjects: 52
Study 26468626 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotary instrumentation (ProTaper™ S1‐S2‐F1‐F2)
Number of subjects: 47
Study 26468626 — intervention group
Group type: COMPARATOR
Intervention: Reciprocating instrumentation (WaveOne™ Primary)
Number of subjects: 47
Study 25119339 — intervention group
Group type: COMPARATOR
Intervention: Iron supplements (0 mg/kg/d)
Number of subjects: 285
Study 25119339 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplements (1 mg/kg/d)
Number of subjects: 285
Study 25119339 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplements (2 mg/kg/d)
Number of subjects: 285
Study 22892751 — intervention group
Group type: EXPERIMENTAL
Intervention: ParaCore (PAR)
Number of subjects: 56
Study 22892751 — intervention group
Group type: EXPERIMENTAL
Intervention: ParaCore + silane (PAR-SIL)
Number of subjects: 56
Study 22892751 — intervention group
Group type: EXPERIMENTAL
Intervention: RelyX Unicem (RXU)
Number of subjects: 56
Study 22892751 — intervention group
Group type: EXPERIMENTAL
Intervention: RelyX Unicem + silane (RXU-SIL)
Number of subjects: 56
Study 22892751 — intervention group
Group type: EXPERIMENTAL
Intervention: RelyX ARC (RXA)
Number of subjects: 56
Study 22892751 — intervention group
Group type: EXPERIMENTAL
Intervention: RelyX ARC + silane (RXA-SIL)
Number of subjects: 56
Study 22892751 — intervention group
Group type: COMPARATOR
Intervention: Negative control (NEG-CON)
Number of subjects: 56
Study 22892751 — intervention group
Group type: COMPARATOR
Intervention: Positive control (POS-CON)
Number of subjects: 56
Study 20488346 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT), 10 sessions
Number of subjects: 0
Study 20488346 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 18833859 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1: Intact teeth (no preparation)
Number of subjects: 60
Study 18833859 — intervention group
Group type: COMPARATOR
Intervention: Group 2: Non-restored teeth
Number of subjects: 60
Study 18833859 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3: Restored with amalgam
Number of subjects: 60
Study 18833859 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 4: Restored with dentin bonding system (DBS) and resin composite (CR)
Number of subjects: 60
Study 18833859 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 5: Restored with indirect hybrid ceramic inlay material
Number of subjects: 60
Study 18833859 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 6: Restored with polyethylene ribbon fiber and DBS/CR
Number of subjects: 60
Study 15891932 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-based learning (PBL)
Number of subjects: 98
Study 15891932 — intervention group
Group type: COMPARATOR
Intervention: Structured course (SC)
Number of subjects: 98
Study 11838889 — intervention group
Group type: EXPERIMENTAL
Intervention: Food service intervention (training workshops for cooks and monthly site visits)
Number of subjects: 9
Study 11838889 — intervention group
Group type: EXPERIMENTAL
Intervention: Food service intervention
Number of subjects: 9
Study 11838889 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 9
Study 10367619 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine production of IL-1 per monocyte
Number of subjects: 34
Study 10367619 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine production of IL-6 per monocyte
Number of subjects: 34
Study 10367619 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine production of TNF-alpha per monocyte
Number of subjects: 34
Study 10367619 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine production of IFN-gamma per lymphocyte
Number of subjects: 34
Study 10367619 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine production of G-CSF
Number of subjects: 34
Study 10367619 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphocyte proliferative response with PHA
Number of subjects: 34
Study 7564843 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharyngeal constrictor myotomy
Number of subjects: 29
Study 7564843 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral pharyngeal plexus neurectomy
Number of subjects: 29
Study 7564843 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral pharyngeal plexus neurectomy with small drainage myotomy limited to the cricopharyngeus
Number of subjects: 29
Study 7564843 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 29
Study 1981698 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.50 mg etizolam
Number of subjects: 36
Study 1981698 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg etizolam
Number of subjects: 36
Study 1981698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 7033788 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 100
Study 7033788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 30782877 — intervention group
Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training for approximately 5 weeks
Number of subjects: 100
Study 30782877 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 100
Study 28414728 — intervention group
Group type: EXPERIMENTAL
Intervention: Clown-care (n = 20)
Number of subjects: 45
Study 28414728 — intervention group
Group type: COMPARATOR
Intervention: Standard-care (n = 25)
Number of subjects: 45
Study 28414728 — intervention group
Group type: COMPARATOR
Intervention: Clown-care followed by Standard-care
Number of subjects: 45
Study 28414728 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection-naïve children with clown-care
Number of subjects: 45
Study 28414728 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple procedures with clown-care
Number of subjects: 45
Study 28414728 — intervention group
Group type: COMPARATOR
Intervention: Standard-care first experience
Number of subjects: 45
Study 25867700 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper Next
Number of subjects: 70
Study 25867700 — intervention group
Group type: EXPERIMENTAL
Intervention: TF Adaptive
Number of subjects: 70
Study 25867700 — intervention group
Group type: EXPERIMENTAL
Intervention: WaveOne
Number of subjects: 70
Study 25867700 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciproc
Number of subjects: 70
Study 25867700 — intervention group
Group type: EXPERIMENTAL
Intervention: OneShape
Number of subjects: 70
Study 25867700 — intervention group
Group type: EXPERIMENTAL
Intervention: SAF
Number of subjects: 70
Study 25867700 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 70
Study 23953024 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 1843
Study 23953024 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 1843
Study 23953024 — intervention group
Group type: COMPARATOR
Intervention: MoodGYM (active control)
Number of subjects: 1843
Study 21272417 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse practitioners (NP) lifestyle counselling
Number of subjects: 341